Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

Contact Us

Differential Diagnosis Of MS Patients Versus Disease State Controls and Classification of MS Subtypes Using Serum Proteomics

October 26, 2022inByCommentNo Comments
Click here

© 2025 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us